Cargando…
Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors
Despite the ongoing progress in cancer research, the global cancer burden has increased to 18.1 million new cases and 9.6 million deaths in 2018. Gynecological cancers, such as ovarian, endometrial, and cervical cancers, considerably contribute to global cancer burden, leading to $5,862.6, $2,945.7,...
Autores principales: | Grywalska, Ewelina, Sobstyl, Małgorzata, Putowski, Lechosław, Roliński, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801535/ https://www.ncbi.nlm.nih.gov/pubmed/31547532 http://dx.doi.org/10.3390/ijms20194705 |
Ejemplares similares
-
Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
por: Grywalska, Ewelina, et al.
Publicado: (2018) -
Toll-Like Receptor 2 Expression as a New Hallmark of Advanced Endometriosis
por: Sobstyl, Małgorzata, et al.
Publicado: (2020) -
The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer
por: Sobstyl, Małgorzata, et al.
Publicado: (2022) -
Impact of Methimazole Treatment on Magnesium Concentration and Lymphocytes Activation in Adolescents with Graves’ Disease
por: Klatka, Maria, et al.
Publicado: (2013) -
Possible Immunomodulating Effect of Retinol on Cytokines Secretion in Patients with Recurrent Furunculosis
por: Nowicka, Danuta, et al.
Publicado: (2017)